CVE-2023-7103

CVE-2023-7103 is a critical-severity vulnerability in Zksoftware Uface 5 with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-305.

Key facts

Description

Authentication Bypass by Primary Weakness vulnerability in ZKSoftware Biometric Security Solutions UFace 5 allows Authentication Bypass. This issue affects UFace 5: through 12022024.

Frequently asked questions

What is CVE-2023-7103?
Authentication Bypass by Primary Weakness vulnerability in ZKSoftware Biometric Security Solutions UFace 5 allows Authentication Bypass. This issue affects UFace 5: through 12022024.
How severe is CVE-2023-7103?
CVE-2023-7103 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-7103 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (46th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-7103?
CVE-2023-7103 affects Zksoftware Uface 5. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-7103?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
Does CVE-2023-7103 have an EU (EUVD) identifier?
Yes. CVE-2023-7103 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-59287.
When was CVE-2023-7103 published?
CVE-2023-7103 was published on 2024-03-05 and last updated on 2026-06-17.

References

Affected products (1)

Other CWE-305 vulnerabilities

Browse all CWE-305 vulnerabilities →